Clinical Trial Update: Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a reduced MBF regimen for patients 55 years and older with myeloid malignancies, currently recruiting and focusing on diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Drugs mentioned

• MBF regimen

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Disease-free Survival | Phase 2 | Status: RECRUITING